Catalyst Wire Dossier Catalyst Wire Dossier

C2-R215

· Alvogen Korea
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for C2-R215, covering 2016-12-29 to 2016-12-29. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Drug Drug Interaction Clinical Trial of C1-R215 and C2-R215 in Healthy Male Volunteers [Phase 1]

See pricing